Abstract
The expression of cytochrome P450 (CYP)-dependent mono-oxygenases in the prostate is important, as it will determine the rate of activation of potential carcinogens as well as the metabolism of hormones with implications in diseases of the prostate. In addition, the levels of cytochromes P450 in prostatic tumours may well be determinants of the outcome of therapy involving P450 substrates such as anti-androgens.
Original language | English |
---|---|
Pages (from-to) | 880-886 |
Number of pages | 7 |
Journal | European Journal of Clinical Investigation |
Volume | 31 |
Issue number | 10 |
DOIs | |
Publication status | Published - 2001 |
Keywords
- Cytochrome P450
- Gene expression
- prostate
- multiplex
- reverse transcriptase PCR